EUCAST disc diffusion criteria for the detection of mecA-Mediated β-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 08 03 2018
revised: 24 04 2019
accepted: 07 05 2019
pubmed: 21 5 2019
medline: 2 7 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

Until recently, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommended the cefoxitin disc to screen for mecA-mediated β-lactam resistance in Staphylococcus pseudintermedius. A recent study indicated that cefoxitin was inferior to oxacillin in this respect. We have re-evaluated cefoxitin and oxacillin discs for screening for methicillin resistance in S. pseudintermedius. We included 224 animal and human S. pseudintermedius isolates from Europe (n = 108) and North America (n = 116), of which 109 were mecA-positive. Disc diffusion was performed per EUCAST recommendations using 30-μg cefoxitin and 1-μg oxacillin discs from three manufacturers and Mueller-Hinton agar from two manufacturers. Cefoxitin inhibition zones ranged from 6 to 33 mm for mecA-positive S. pseudintermedius (MRSP) and from 29 to 41 mm for mecA-negative S. pseudintermedius (MSSP). The corresponding oxacillin zone intervals were 6-20 mm and 19-30 mm. For cefoxitin 16% (95% CI 14.8-18.0%) of the isolates were in the area where positive and negative results overlapped. For oxacillin the corresponding number was 2% (1.6-2.9%). For oxacillin a breakpoint of susceptible (S) ≥ 20 mm and resistant (R) <20 mm resulted in only 0.4% and 1.1% very major error and major error rates respectively. This investigation confirms that the 1-μg oxacillin disc predicts mecA-mediated methicillin resistance in S. pseudintermedius better than the 30-μg cefoxitin disc. For a 1-μg oxacillin disc we propose that 20 mm should be used as cut off for resistance, i.e. isolates with a zone diameter <20 mm are resistant to all β-lactam antibiotics except those with activity against methicillin-resistant staphylococci.

Identifiants

pubmed: 31108230
pii: S1198-743X(19)30215-0
doi: 10.1016/j.cmi.2019.05.002
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
MecA protein, Staphylococcus pseudintermedius 0
Cefoxitin 6OEV9DX57Y
Oxacillin UH95VD7V76

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122.e1-122.e6

Informations de copyright

Copyright © 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Auteurs

R Skov (R)

Statens Serum Institut, Copenhagen, Denmark. Electronic address: rsk@ssi.dk.

A Varga (A)

EUCAST Development Laboratory, Växjö, Sweden.

E Matuschek (E)

EUCAST Development Laboratory, Växjö, Sweden.

J Åhman (J)

EUCAST Development Laboratory, Växjö, Sweden.

D Bemis (D)

University of Tennessee, Knoxville, TN, USA.

B Bengtsson (B)

National Veterinary Institute, Uppsala, Sweden.

M Sunde (M)

Norwegian Veterinary Institute, Oslo, Norway.

R Humphries (R)

Accelerate Diagnostics, Tucson AZ, USA, University of California, Los Angeles, CA, USA.

L Westblade (L)

Weill Cornell Medicine, New York, NY, USA.

L Guardabassi (L)

Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; Department of Pathobiology and Population Sciences, Royal Veterinary College, Hatfield, United Kingdom.

G Kahlmeter (G)

EUCAST Development Laboratory, Växjö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH